• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Best Managed Accounts
  • Forex Robots
  • Forex Brokers
  • Forex Signals
  • Social Trading Platforms
  • Community Reviews

  • Robots
  • Start Guide
  • Glossary
  • Basics
    • Currency Pairs
    • Charts
    • Candlesticks
    • Trading Tips
  • Strategies
    • Technical Analysis
    • Fundamental Analysis
    • Day Trading
    • Scalping
    • Swing Trading
    • Trend Following
  • News
  • Reviews
    • Forex Robots
    • Forex Brokers
  • Mustreads
  • Crypto Trading

Promising Results for Novo Nordisk’s Obesity Drug

August 9, 2023 by Forex Winner Leave a Comment

Novo Nordisk, a Danish pharmaceutical company, saw its shares rise by 16% after the announcement of positive results from a five-year study on its obesity drug. The study revealed that the drug, marketed as Wegovy, reduces the risk of major adverse cardiovascular events in overweight or obese adults by 20%.

Semaglutide, the active component of Wegovy, proved to have a safe and well-tolerated profile during the trial. Furthermore, it demonstrated a statistically significant and superior reduction in cardiovascular events compared to the control group. The trial involved 17,604 overweight or obese adults over the age of 45 with established cardiovascular disease but no prior history of diabetes.

The results are particularly encouraging as there are currently no approved weight management medications that effectively reduce the risk of heart attack, stroke, or cardiovascular death while managing weight. Martin Holst Lange, the executive vice president for Development at Novo Nordisk, expressed excitement about these findings, stating that semaglutide 2.4 mg shows promise in reducing cardiovascular events.

Novo Nordisk plans to seek regulatory approvals for an expansion of the label indication for semaglutide 2.4 mg in the U.S. and the EU in 2023. This development opens up new possibilities for individuals struggling with obesity and related cardiovascular risks.

Best Forex Robots ›

Compare leading trading systems on the market

Filed Under: Forex News Tagged With: cardiovascular events, obesity, semaglutide, Wegovy, weight management

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Best Forex Robots

  1. Techberry 8.7
  2. Happy Forex 8.0
  3. Forex Fury 7.7
  4. Promax Gold EA 6.8
  5. Gump EA 6.4

Best Forex Brokers

  1. Techberry 8.7
  2. XM 8.2
  3. eToro 8.1
  4. Pepperstone 8.1
  5. IG 8.0

Latest News

SIM Mining Announces Global Launch of Next-Gen Cloud Mining Platform!

July 15, 2025

RICH Miner leads the Ripple cloud mining revolution – converting XRP into daily stable income

July 14, 2025

GCCI hosts strategic meeting with APMIA Chairman – Daily Times

July 13, 2025

Footer

Forex Broker Reviews

Hot Forex

HotForex Review

November 10, 2019 By Forex Winner

icm capital

ICM Capital Review

September 13, 2019 By Forex Winner

lmfx

LMFX Review

December 23, 2019 By Forex Winner

Forex Robot Reviews

Earn2Trade Review

August 20, 2023 By Shandor Brenner

FundedNext Review

August 16, 2023 By Shandor Brenner

Topstep Forex Review

August 14, 2023 By Shandor Brenner

EMAIL NEWSLETTER

Sign up to receive exclusive forex trading guides and insights from our team of experts!

Copyright © 2025 · Forex Traders Guide · About Us · Contact Us
Privacy Policy · Risk Disclosure